A Multimodal Imaging Study of Dopamine in Early Psychosis

NCT06977308 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

115

Enrollment

OTHER

Sponsor class

Conditions

Clinical High Risk for Psychosis (CHR)

Interventions

DRUG: Methylphenidate (MPH)
DRUG: [11C]raclopride

Sponsor

New York State Psychiatric Institute

Collaborators

[object Object]
[object Object]
[object Object]